This PMCF study is to obtain patient feedback using online questionnaires. There will be no involvement from healthcare professionals (HCPs) or investigator sites. Up to 100 Patients are being recruited by My Health Focus through their website. The study is performed throughout the UK except Northern Ireland with no sites involved in this study. Patients apply directly to participate in the study and the testing and questionnaire responses are completed at home.
Patients with psoriasis of any severity previously diagnosed by a Healthcare Professional (HCP).
Patients normally managing their skin condition by regular and ongoing use of leave-on emollient(s).
Patients willing to incorporate Doublebase Once into their normal skin condition management routine for approximately 1 month as their only emollient and instead of their usual emollient
Does not regularly use an emollient
Known history of intolerance or skin sensitivity to any of the ingredients of Doublebase Once (as identified on the Patient Information Sheet and product labelling), or similar products used.
Currently participating in a study involving an investigational medicinal product/medical device or having participated in the previous 30 days.
Patients currently residing in Northern Ireland (this is due to the different approval process)
Single group
Doublebase Once
DeviceOnce Daily Emollient
Emollient performance
Patient reported questionnaire responses on skin condition and product use. Scoring of 0 - 10 to specific skin condition and product parameters (0=Strongly agree - 10 strongly disagree)
Adverse Device effects and Device deficiencies
Reported related adverse device effects and Device deficiencies
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
